Showing results (111-120 of 181) with videos related to
Sort By:
Pageof 19
Cytometry|May 1, 1994
Tumor cell kinetics using two labels and flow cytometryM A Ritter, J F Fowler, Y J Kim, et al.AORN Journal|December 1, 2001
Mobile linear accelerators for intraoperative radiation therapyA S Beddar, M A Domanovic, M L Kubu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissuesT J Kinsella, K A Kunugi, K A Vielhuber, et al.Radiation Oncology Investigations|July 4, 1998
Computed tomographic evaluation of radiation pneumonitis in a canine modelL J Forrest, P A Mahler, D M Vail, et al.Biochemical and Biophysical Research Communications|December 16, 1987
Alzheimer's disease fibroblasts have normal repair of N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA damage determined by the alkaline elution techniqueT J Kinsella, P P Dobson, A J Fornace, et al.Seminars in Radiation Oncology|October 26, 2001
When X-ray-inducible proteins meet DNA double strand break repairK S Leskov, T Criswell, S Antonio, et al.AORN Journal|October 23, 2001
A new approach to intraoperative radiation therapyA S Beddar, M L Kubu, M A Domanovic, et al.International Journal of Radiation Oncology, Biology, Physics|March 1, 1991
Long-term follow-up of Ewing's sarcoma of bone treated with combined modality therapyT J Kinsella, J S Miser, B Waller, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1997
Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trialS P Tannehill, M P Mehta, M Larson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1984
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experienceW J Tester, T J Kinsella, B Waller, et al.Pageof 19